Apoprotein measurements and their clinical application.

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Clinical Chemistry

Background:

• Apoproteins are integral components of lipoproteins, such as apoprotein B with very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL), and apoprotein A-I with high-density lipoprotein (HDL).
• Plasma concentrations and metabolic status of lipoproteins are reflected in the levels of their associated apoproteins.

Purpose of the Study:

• To highlight the significance of apoprotein B, apoprotein A-I, and Lp(a) lipoprotein levels as predictors of coronary heart disease (CHD) risk.
• To emphasize the added value of apoprotein measurements in cardiovascular risk assessment compared to traditional lipid profiles.
• To discuss clinical considerations for utilizing apoprotein measurements in patient care and public health.

Main Methods:

• Analysis of apoprotein levels in relation to lipoprotein metabolism.
• Evaluation of apoprotein B, apoprotein A-I, and Lp(a) as biomarkers for coronary heart disease risk.
• Consideration of clinical utility, standardization, reference values, and cost-effectiveness of apoprotein assays.

Main Results:

• Apoprotein B and apoprotein A-I levels, along with Lp(a) lipoprotein, are significant predictors of coronary heart disease risk.
• Apoprotein measurements provide crucial information on lipoprotein metabolism and cardiovascular risk not obtainable from standard lipid and lipoprotein lipid levels.
• Apoproteins can aid in specific diagnostic questions and assessing therapeutic responses.

Conclusions:

• Apoprotein measurements offer valuable insights into cardiovascular health and disease prediction.
• The clinical application of apoprotein testing depends on factors like setting, assay standardization, reference data, and cost.
• Apoproteins serve as important diagnostic and therapeutic monitoring tools in specific clinical scenarios.